Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity

被引:85
|
作者
Tun-Kyi, Adrian [1 ]
Finn, Greg [1 ]
Greenwood, Alex [2 ]
Nowak, Michael [1 ]
Lee, Tae Ho [1 ]
Asara, John M. [1 ]
Tsokos, George C. [1 ]
Fitzgerald, Kate [3 ]
Israel, Elliot [4 ]
Li, Xiaoxia [5 ]
Exley, Mark [1 ]
Nicholson, Linda K. [2 ]
Lu, Kun Ping [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA
[2] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA
[3] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] Cleveland Clin Fdn, Dept Immunol, Cleveland, OH 44195 USA
基金
美国国家卫生研究院;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; PATTERN-RECOGNITION RECEPTORS; MURINE CYTOMEGALOVIRUS; INTERLEUKIN-1; RECEPTOR; ADAPTIVE IMMUNITY; ALPHA INDUCTION; VIRAL-INFECTION; DENDRITIC CELLS; RESPONSES; KINASE;
D O I
10.1038/ni.2069
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Toll-like receptors (TLRs) shape innate and adaptive immunity to microorganisms. The enzyme IRAK1 transduces signals from TLRs, but mechanisms for its activation and regulation remain unknown. We found here that TLR7 and TLR9 activated the isomerase Pin1, which then bound to IRAK1; this resulted in activation of IRAK1 and facilitated its release from the receptor complex to activate the transcription factor IRF7 and induce type I interferons. Consequently, Pin1-deficient cells and mice failed to mount TLR-mediated, interferon-dependent innate and adaptive immune responses. Given the critical role of aberrant activation of IRAK1 and type I interferons in various immune diseases, controlling IRAK1 activation via inhibition of Pin1 may represent a useful therapeutic approach.
引用
收藏
页码:733 / U142
页数:10
相关论文
共 50 条
  • [41] Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling
    De Nardo, Dominic
    Balka, Katherine R.
    Gloria, Yamel Cardona
    Rao, Vikram R.
    Latz, Eicke
    Masters, Seth L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (39) : 15195 - 15207
  • [42] The promotion of type 1 T helper cell responses to cationic polymers in vivo via toll-like receptor-4 mediated IL-12 secretion
    Chen, Huan
    Li, Pei
    Yin, Yuan
    Cai, Xing
    Huang, Zhen
    Chen, Jiangning
    Dong, Lei
    Zhang, Junfeng
    BIOMATERIALS, 2010, 31 (32) : 8172 - 8180
  • [43] Serum amyloid A 1 induces suppressive neutrophils through the Toll-like receptor 2-mediated signaling pathway to promote progression of breast cancer
    Niu, Xingjian
    Yin, Lei
    Yang, Xudong
    Yang, Yue
    Gu, Yucui
    Sun, Yutian
    Yang, Ming
    Wang, Yiran
    Zhang, Qingyuan
    Ji, Hongfei
    CANCER SCIENCE, 2022, 113 (04) : 1140 - 1153
  • [44] Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3-IRF3 signaling and type I interferons in dendritic cells
    Wang, Ce
    Zhuang, Yan
    Zhang, Yijuan
    Luo, Zichao
    Gao, Ningning
    Li, Ping
    Pan, Hong
    Cai, Lintao
    Ma, Yifan
    VACCINE, 2012, 30 (32) : 4790 - 4799
  • [45] Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus
    Donna L Thibault
    Kareem L Graham
    Lowen Y Lee
    Imelda Balboni
    Paul J Hertzog
    Paul J Utz
    Arthritis Research & Therapy, 11
  • [46] Toll-like receptor-7 ligand imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis
    Sainathan, Satheesh K.
    Bishnupuri, Kumar S.
    Aden, Konrad
    Luo, Qizhi
    Houchen, Courtney W.
    Anant, Shrikant
    Dieckgraefe, Brian K.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (05) : 955 - 967
  • [47] Type I Interferons Protect From Toll-Like Receptor 9-Associated Liver Injury and Regulate IL-1 Receptor Antagonist in Mice
    Petrasek, Jan
    Dolganiuc, Angela
    Csak, Timea
    Kurt-Jones, Evelyn A.
    Szabo, Gyongyi
    GASTROENTEROLOGY, 2011, 140 (02) : 697 - U450
  • [48] Feline calicivirus strain 2280 p30 antagonizes type I interferon-mediated antiviral innate immunity through directly degrading IFNAR1 mRNA
    Tian, Jin
    Kang, Hongtao
    Huang, Jiapei
    Li, Zhijie
    Pan, Yudi
    Li, Yin
    Chen, Si
    Zhang, Jikai
    Yin, Hang
    Qu, Liandong
    PLOS PATHOGENS, 2020, 16 (10)
  • [49] Inhibition of DC-SIGN-mediated transmission of human immunodeficiency virus type 1 by Toll-like receptor 3 signalling in breast milk macrophages
    Yagi, Yukie
    Watanabe, Eri
    Watari, Eiji
    Shinya, Eiji
    Satomi, Misao
    Takeshita, Toshiyuki
    Takahashi, Hidemi
    IMMUNOLOGY, 2010, 130 (04) : 597 - 607
  • [50] Type I interferon/STAT1 signaling regulates UBE2M-mediated antiviral innate immunity in a negative feedback manner
    Kong, Xianghui
    Lu, Xinliang
    Wang, Shibo
    Hao, Jiayue
    Guo, Danfeng
    Wu, Hao
    Jiang, Yu
    Sun, Yi
    Wang, Jianli
    Zhang, Gensheng
    Cai, Zhijian
    CELL REPORTS, 2023, 42 (01):